As the global economy recovers in 2021 and the supply of the industrial chain improves, the Imatinib Mesylate Tablets market will undergo major changes. According to the latest research, the market size of the Imatinib Mesylate Tablets industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.
The global Imatinib Mesylate Tablets industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.
The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Imatinib Mesylate Tablets market during the next few years. The global Imatinib Mesylate Tablets market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.
This report presents a comprehensive overview, market shares, and growth opportunities of Imatinib Mesylate Tablets market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
100 mg
400 mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Clinics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Teva Pharmaceuticals
Hikma Pharmaceuticals
Apotex Inc
Sun Pharmaceutical Industries
Lupin Limited
Natco Pharma
Getwell Oncology
Table of Content
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Imatinib Mesylate Tablets Market Size 2017-2028
2.1.2 Imatinib Mesylate Tablets Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Imatinib Mesylate Tablets Segment by Type
2.2.1 100 mg
2.2.2 400 mg
2.3 Imatinib Mesylate Tablets Market Size by Type
2.3.1 Imatinib Mesylate Tablets Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Imatinib Mesylate Tablets Market Size Market Share by Type (2017-2022)
2.4 Imatinib Mesylate Tablets Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.5 Imatinib Mesylate Tablets Market Size by Application
2.5.1 Imatinib Mesylate Tablets Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Imatinib Mesylate Tablets Market Size Market Share by Application (2017-2022)
3 Imatinib Mesylate Tablets Market Size by Player
3.1 Imatinib Mesylate Tablets Market Size Market Share by Players
3.1.1 Global Imatinib Mesylate Tablets Revenue by Players (2020-2022)
3.1.2 Global Imatinib Mesylate Tablets Revenue Market Share by Players (2020-2022)
3.2 Global Imatinib Mesylate Tablets Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Imatinib Mesylate Tablets by Regions
4.1 Imatinib Mesylate Tablets Market Size by Regions (2017-2022)
4.2 Americas Imatinib Mesylate Tablets Market Size Growth (2017-2022)
4.3 APAC Imatinib Mesylate Tablets Market Size Growth (2017-2022)
4.4 Europe Imatinib Mesylate Tablets Market Size Growth (2017-2022)
4.5 Middle East & Africa Imatinib Mesylate Tablets Market Size Growth (2017-2022)
5 Americas
5.1 Americas Imatinib Mesylate Tablets Market Size by Country (2017-2022)
5.2 Americas Imatinib Mesylate Tablets Market Size by Type (2017-2022)
5.3 Americas Imatinib Mesylate Tablets Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Imatinib Mesylate Tablets Market Size by Region (2017-2022)
6.2 APAC Imatinib Mesylate Tablets Market Size by Type (2017-2022)
6.3 APAC Imatinib Mesylate Tablets Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Imatinib Mesylate Tablets by Country (2017-2022)
7.2 Europe Imatinib Mesylate Tablets Market Size by Type (2017-2022)
7.3 Europe Imatinib Mesylate Tablets Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Imatinib Mesylate Tablets by Region (2017-2022)
8.2 Middle East & Africa Imatinib Mesylate Tablets Market Size by Type (2017-2022)
8.3 Middle East & Africa Imatinib Mesylate Tablets Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Imatinib Mesylate Tablets Market Forecast
10.1 Global Imatinib Mesylate Tablets Forecast by Regions (2023-2028)
10.1.1 Global Imatinib Mesylate Tablets Forecast by Regions (2023-2028)
10.1.2 Americas Imatinib Mesylate Tablets Forecast
10.1.3 APAC Imatinib Mesylate Tablets Forecast
10.1.4 Europe Imatinib Mesylate Tablets Forecast
10.1.5 Middle East & Africa Imatinib Mesylate Tablets Forecast
10.2 Americas Imatinib Mesylate Tablets Forecast by Country (2023-2028)
10.2.1 United States Imatinib Mesylate Tablets Market Forecast
10.2.2 Canada Imatinib Mesylate Tablets Market Forecast
10.2.3 Mexico Imatinib Mesylate Tablets Market Forecast
10.2.4 Brazil Imatinib Mesylate Tablets Market Forecast
10.3 APAC Imatinib Mesylate Tablets Forecast by Region (2023-2028)
10.3.1 China Imatinib Mesylate Tablets Market Forecast
10.3.2 Japan Imatinib Mesylate Tablets Market Forecast
10.3.3 Korea Imatinib Mesylate Tablets Market Forecast
10.3.4 Southeast Asia Imatinib Mesylate Tablets Market Forecast
10.3.5 India Imatinib Mesylate Tablets Market Forecast
10.3.6 Australia Imatinib Mesylate Tablets Market Forecast
10.4 Europe Imatinib Mesylate Tablets Forecast by Country (2023-2028)
10.4.1 Germany Imatinib Mesylate Tablets Market Forecast
10.4.2 France Imatinib Mesylate Tablets Market Forecast
10.4.3 UK Imatinib Mesylate Tablets Market Forecast
10.4.4 Italy Imatinib Mesylate Tablets Market Forecast
10.4.5 Russia Imatinib Mesylate Tablets Market Forecast
10.5 Middle East & Africa Imatinib Mesylate Tablets Forecast by Region (2023-2028)
10.5.1 Egypt Imatinib Mesylate Tablets Market Forecast
10.5.2 South Africa Imatinib Mesylate Tablets Market Forecast
10.5.3 Israel Imatinib Mesylate Tablets Market Forecast
10.5.4 Turkey Imatinib Mesylate Tablets Market Forecast
10.5.5 GCC Countries Imatinib Mesylate Tablets Market Forecast
10.6 Global Imatinib Mesylate Tablets Forecast by Type (2023-2028)
10.7 Global Imatinib Mesylate Tablets Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Teva Pharmaceuticals
11.1.1 Teva Pharmaceuticals Company Information
11.1.2 Teva Pharmaceuticals Imatinib Mesylate Tablets Product Offered
11.1.3 Teva Pharmaceuticals Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Teva Pharmaceuticals Main Business Overview
11.1.5 Teva Pharmaceuticals Latest Developments
11.2 Hikma Pharmaceuticals
11.2.1 Hikma Pharmaceuticals Company Information
11.2.2 Hikma Pharmaceuticals Imatinib Mesylate Tablets Product Offered
11.2.3 Hikma Pharmaceuticals Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Hikma Pharmaceuticals Main Business Overview
11.2.5 Hikma Pharmaceuticals Latest Developments
11.3 Apotex Inc
11.3.1 Apotex Inc Company Information
11.3.2 Apotex Inc Imatinib Mesylate Tablets Product Offered
11.3.3 Apotex Inc Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Apotex Inc Main Business Overview
11.3.5 Apotex Inc Latest Developments
11.4 Sun Pharmaceutical Industries
11.4.1 Sun Pharmaceutical Industries Company Information
11.4.2 Sun Pharmaceutical Industries Imatinib Mesylate Tablets Product Offered
11.4.3 Sun Pharmaceutical Industries Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Sun Pharmaceutical Industries Main Business Overview
11.4.5 Sun Pharmaceutical Industries Latest Developments
11.5 Lupin Limited
11.5.1 Lupin Limited Company Information
11.5.2 Lupin Limited Imatinib Mesylate Tablets Product Offered
11.5.3 Lupin Limited Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Lupin Limited Main Business Overview
11.5.5 Lupin Limited Latest Developments
11.6 Natco Pharma
11.6.1 Natco Pharma Company Information
11.6.2 Natco Pharma Imatinib Mesylate Tablets Product Offered
11.6.3 Natco Pharma Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Natco Pharma Main Business Overview
11.6.5 Natco Pharma Latest Developments
11.7 Getwell Oncology
11.7.1 Getwell Oncology Company Information
11.7.2 Getwell Oncology Imatinib Mesylate Tablets Product Offered
11.7.3 Getwell Oncology Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Getwell Oncology Main Business Overview
11.7.5 Getwell Oncology Latest Developments
12 Research Findings and Conclusion
Teva Pharmaceuticals
Hikma Pharmaceuticals
Apotex Inc
Sun Pharmaceutical Industries
Lupin Limited
Natco Pharma
Getwell Oncology
*If Applicable.